| Product Name |
Recombinant Human IL2RG Protein |
| Product Overview |
This recombinant human IL2RG protein includes amino acids 23-262aa of the target gene is expressed in Insect cell.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
| Target Uniprot Id |
P31785 |
| Recommended Name |
Cytokine receptor common subunit gamma |
| Gene Name |
IL2RG |
| Synonyms |
Cytokine receptor common subunit gamma , CD132, CIDX, IL-2RG, IMD4, P64, SCIDX, SCIDX1 |
| Species |
Human |
| Predicted Molecular Mass |
29.0 kDa |
| Expression System |
Insect Cell |
| Expression Range |
23-262aa |
| Tag |
N-6His |
| Purity |
>95% |
| Formulation |
Lyophilized |
| Buffer |
Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
| Storage Condition |
1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
| Reconstitution Instruction |
Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
| Applications |
Positive Control; Immunogen; SDS-PAGE; WB |
| Research Area |
Cancer |
| Target Function |
Common subunit for the receptors for a variety of interleukins. Probably in association with IL15RA, involved in the stimulation of neutrophil phagocytosis by IL15. |
| Subcellular Location |
Cell membrane; Single-pass type I membrane protein. Cell surface. |
| Protein Family |
Type I cytokine receptor family, Type 5 subfamily |
| Associated Diseases |
Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID); X-linked combined immunodeficiency (XCID) |
